Scinai Immunotherapeutics (SCNI) Equity Income (2025 - 2026)
Scinai Immunotherapeutics (SCNI) reported Equity Income of $3.6 million for Q1 2026, up 329.74% on a YoY basis from $832370.2 in Q1 2025, and down 37.15% sequentially from $5.7 million in Q2 2025.
Scinai Immunotherapeutics (SCNI) Equity Income (2025 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 2 years of Equity Income data on file, last reported at $3.6 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.54 Bn | 424.15 Mn | -1.12 Mn | 3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Mar 31, 2025 | -1.56 Mn |